Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Symptom Burden in Pancreatic Cancer
NCT01693523Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2013
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in pancreatic cancer (PC), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2013; status: completed.
02
Drugs
minocycline
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01693523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01693523.